Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
weight-loss and diet control industry
weight-loss and diet control industry
Newsletters
Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
By
Emma Hinchliffe
August 7, 2025
The key to a long life is avoiding the ‘poisonous 5 P’s,’ says one of the world’s top anti-aging experts
By
Alexa Mikhail
May 24, 2025
Tech
Novo ousts CEO Jorgensen after Lilly competition hits shares
By
Eric Pfanner
and
Bloomberg
May 16, 2025
Health
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
By
Jonel Aleccia
and
The Associated Press
May 12, 2025
Health
Currency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars
By
Ryan Hogg
May 9, 2025
Finance
WeightWatchers files for bankruptcy as it struggles for a place in a weight loss world dominated by Ozempic and Wegovy
By
The Associated Press
May 7, 2025
Health
CVS strikes a deal to offer Wegovy at a discount
By
Chris Morris
May 1, 2025
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By
Bloomberg
,
Madison Muller
,
Ike Swetlitz
and
Naomi Kresge
February 21, 2025
Finance
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By
Ryan Hogg
February 19, 2025
Health
The dietary supplements you think are improving your health may be damaging your liver, research warns
By
Lindsey Leake
February 19, 2025
Health
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By
Lindsey Leake
February 11, 2025
Health
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
By
Ryan Hogg
February 5, 2025
Health
Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results
By
Ryan Hogg
February 4, 2025
Health
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By
Lindsey Leake
February 3, 2025
Health
Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By
Lindsey Leake
January 29, 2025
Most Popular
Future of Work
Meet a 55-year-old automotive technician in Arkansas who didn’t care if his kids went to college: ‘There are options’
By
Muskaan Arshad
Future of Work
A Walmart employee nearly doubled her pay after entering its pipeline for skilled tradespeople. 'I was able to move out...
By
Anne D'Innocenzio
and
The Associated Press
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash...
By
Sasha Rogelberg